Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To evaluate the safety and immunogenicity of the MVA-SIBP vaccine using a double-blind, randomized, controlled, age de-escalation design conducted in Kinshasa, Democratic Republic of the Congo (DRC).
Epistemonikos ID: a750860e558d514c0fb75090bec285e7759321e0
First added on: Nov 29, 2025